Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
354	HK$3.07	3.7%	-40.6%	HK$7.7b	HK$4.02	20.7	30.2%	1.5%	Software
AVIA	Rp324.00	2.5%	-27.0%	Rp19.2t	Rp510.80	10.6	5.8%	6.8%	Materials
PGC	AU$0.14	-6.7%	-64.1%	AU$231.7m	AU$0.25	0.1	96.0%	n/a	Healthcare
OU8	S$1.61	7.3%	-9.0%	S$1.4b	S$1.88	11.8	-0.3%	2.5%	Real Estate Management and Development
FCL	AU$2.05	-2.8%	-22.6%	AU$706.9m	AU$3.32	457.4	39.2%	n/a	Software
BTPS	Rp1,030.00	3.0%	-28.0%	Rp7.9t	Rp1,463.50	0.8	10.8%	3.8%	Banks
KLBF	Rp730.00	-2.0%	-52.3%	Rp33.0t	Rp1,316.47	9.1	7.4%	4.9%	Pharmaceuticals & Biotech
SIDO New	Rp388.00	3.2%	-24.7%	Rp11.4t	Rp518.50	10.0	6.4%	9.5%	Household
1837 New	HK$1.61	-9.0%	117.6%	HK$3.5b	HK$2.16	11.5	17.9%	4.4%	Food, Beverage & Tobacco
BCI	AU$0.41	-1.2%	16.9%	AU$1.2b	AU$0.63	319.0	47.6%	0%	Materials
SECB	₱62.65	-4.9%	-16.9%	₱47.2b	₱98.75	0.3	15.3%	4.8%	Banks
EW	₱11.98	-1.6%	7.7%	₱27.0b	₱13.70	0.3	n/a	5.7%	Banks
FNLC	US$33.79	-0.2%	32.8%	US$377.1m	n/a	1.3	n/a	4.4%	Banks
BILI A	SEK 142.20	0.1%	9.6%	SEK 13.0b	SEK 162.00	16.2	15.3%	4.2%	Retail
GABC	US$47.20	-1.0%	19.1%	US$1.8b	US$50.20	1.5	5.6%	2.6%	Banks
CVSG	UK£12.58	0.3%	2.3%	UK£869.5m	UK£16.33	52.7	23.4%	0.7%	Healthcare
ANGX	US$4.09	11.4%	n/a	US$755.0m	US$8.00	2.0	59.6%	n/a	Media
CEVI	SEK 134.40	-1.6%	-25.6%	SEK 3.2b	SEK 171.25	23.9	17.2%	2.0%	Healthcare
NXR.UN	CA$8.17	-1.4%	4.1%	CA$800.0m	CA$8.50	0.5	3.0%	7.8%	Real Estate
ECEL	UK£1.11	0.5%	-28.6%	UK£108.5m	UK£2.05	11.3	31.7%	5.8%	Capital Goods
RCEL New	US$4.02	-19.6%	-24.9%	US$121.6m	US$9.00	1.7	64.0%	n/a	Pharmaceuticals & Biotech
PEBO	US$38.22	-0.7%	23.1%	US$1.4b	US$39.17	1.1	14.5%	4.4%	Banks
APPN	US$25.18	2.0%	-12.1%	US$1.9b	US$26.20	2088.7	108.9%	n/a	Software
UNB	US$24.80	-0.04%	-7.2%	US$111.5m	n/a	1.4	n/a	5.8%	Banks

Undervalued Small Caps With Insider Buying